NCT06136312Completed
Clinical Investigation of the Multi4 System
A Clinical Investigation to Confirm Performance and Safety of the Multi4 System in Patients With Suspected Recurrent Bladder Cancer Lesions
Source: ClinicalTrials.gov · Last updated 9 Apr 2025
Brief summary (registry, in English)
A Clinical Investigation to Confirm Performance and Safety of the Multi4 System in Patients with Suspected Recurrent Bladder Cancer Lesions
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 18 (actual)
- First submitted
- 8 Nov 2023
- Start date
- 1 Dec 2023
- Primary completion date
- 2 Apr 2025
- Lead sponsor
- Multi4 Medical Ab
- Diseases
- Bladder cancer
- NCT number
- NCT06136312
What you commit to
- Study type: Interventional
- Participants enrolled: 18
- From 1 Dec 2023 to the primary completion date, 2 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Current/ongoing untreated urinary tract infection
Other
- Implantable Cardioverter Defibrillator (ICD) that cannot be inactivated
- Pregnancy or breastfeeding
- Be identified by the Investigator as inappropriate from a medical or compliance perspective to participate in this investigation
Who the study is looking for
- Previous bladder cancer Ta/T1 G1-3
- Recurrence of urinary superficial/ non-muscle-invasive bladder cancer visible at cystoscopy, estimated size \< 10 mm
- Willingness and ability to provide informed consent
- Age ≥18 years
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sahlgrenska University Hospital Coordinator of this site? Confirm its status | Gothenburg | Sweden | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.